198 related articles for article (PubMed ID: 36261538)
21. Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption.
Schepper JD; Collins FL; Rios-Arce ND; Raehtz S; Schaefer L; Gardinier JD; Britton RA; Parameswaran N; McCabe LR
J Bone Miner Res; 2019 Apr; 34(4):681-698. PubMed ID: 30690795
[TBL] [Abstract][Full Text] [Related]
22. Administration of
Hsiao YP; Chen HL; Tsai JN; Lin MY; Liao JW; Wei MS; Ko JL; Ou CC
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444952
[TBL] [Abstract][Full Text] [Related]
23. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling.
Thomas CM; Hong T; van Pijkeren JP; Hemarajata P; Trinh DV; Hu W; Britton RA; Kalkum M; Versalovic J
PLoS One; 2012; 7(2):e31951. PubMed ID: 22384111
[TBL] [Abstract][Full Text] [Related]
24.
Tenorio-Jiménez C; Martínez-Ramírez MJ; Del Castillo-Codes I; Arraiza-Irigoyen C; Tercero-Lozano M; Camacho J; Chueca N; García F; Olza J; Plaza-Díaz J; Fontana L; Olivares M; Gil Á; Gómez-Llorente C
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31370223
[TBL] [Abstract][Full Text] [Related]
25. Influence of dietary supplementation with Lactobacillus reuteri on the oral flora of healthy subjects.
Sinkiewicz G; Cronholm S; Ljunggren L; Dahlén G; Bratthall G
Swed Dent J; 2010; 34(4):197-206. PubMed ID: 21306085
[TBL] [Abstract][Full Text] [Related]
26. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.
Spinler JK; Taweechotipatr M; Rognerud CL; Ou CN; Tumwasorn S; Versalovic J
Anaerobe; 2008 Jun; 14(3):166-71. PubMed ID: 18396068
[TBL] [Abstract][Full Text] [Related]
27.
He B; Hoang TK; Tian X; Taylor CM; Blanchard E; Luo M; Bhattacharjee MB; Freeborn J; Park S; Couturier J; Lindsey JW; Tran DQ; Rhoads JM; Liu Y
Front Immunol; 2019; 10():385. PubMed ID: 30899262
[TBL] [Abstract][Full Text] [Related]
28. FolC2-mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri.
Thomas CM; Saulnier DM; Spinler JK; Hemarajata P; Gao C; Jones SE; Grimm A; Balderas MA; Burstein MD; Morra C; Roeth D; Kalkum M; Versalovic J
Microbiologyopen; 2016 Oct; 5(5):802-818. PubMed ID: 27353144
[TBL] [Abstract][Full Text] [Related]
29. Probiotics and gut health in infants: A preliminary case-control observational study about early treatment with Lactobacillus reuteri DSM 17938.
Savino F; Fornasero S; Ceratto S; De Marco A; Mandras N; Roana J; Tullio V; Amisano G
Clin Chim Acta; 2015 Dec; 451(Pt A):82-7. PubMed ID: 25704298
[TBL] [Abstract][Full Text] [Related]
30.
Wang G; Huang S; Cai S; Yu H; Wang Y; Zeng X; Qiao S
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751784
[No Abstract] [Full Text] [Related]
31. Effect of Limosilactobacillus reuteri ZJF036 on Growth Performance and Gut Microbiota in Juvenile Beagle Dogs.
Zhao D; Zhang R; Wang J; Zhang X; Liu K; Zhang H; Liu H
Curr Microbiol; 2023 Mar; 80(5):155. PubMed ID: 36995478
[TBL] [Abstract][Full Text] [Related]
32. Glycerol strengthens probiotic effect of Limosilactobacillus reuteri in oral biofilms: A synergistic synbiotic approach.
Van Holm W; Verspecht T; Carvalho R; Bernaerts K; Boon N; Zayed N; Teughels W
Mol Oral Microbiol; 2022 Dec; 37(6):266-275. PubMed ID: 36075698
[TBL] [Abstract][Full Text] [Related]
33. Multidisciplinary and Comparative Investigations of Potential Psychobiotic Effects of
Beck BR; Park GS; Jeong DY; Lee YH; Im S; Song WH; Kang J
Front Cell Infect Microbiol; 2019; 9():269. PubMed ID: 31404163
[TBL] [Abstract][Full Text] [Related]
34.
Maya-Barrios A; Lira-Hernandez K; Jiménez-Escobar I; Hernández L; Ortiz-Hernandez A; Jiménez-Gutiérrez C; López-Velázquez G; Gutiérrez-Castrellón P
Benef Microbes; 2021 Apr; 12(2):137-145. PubMed ID: 33789556
[TBL] [Abstract][Full Text] [Related]
35. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
[TBL] [Abstract][Full Text] [Related]
36. Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis.
Piccioni A; Franza L; Vaccaro V; Saviano A; Zanza C; Candelli M; Covino M; Franceschi F; Ojetti V
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441008
[TBL] [Abstract][Full Text] [Related]
37. Monospecies probiotic preparation and administration with downstream analysis of sex-specific effects on gut microbiome composition in mice.
Di Gesù CM; Matz LM; Fultz R; Bolding IJ; Buffington SA
STAR Protoc; 2023 Sep; 4(3):102386. PubMed ID: 37379217
[TBL] [Abstract][Full Text] [Related]
38. Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri.
Hemarajata P; Gao C; Pflughoeft KJ; Thomas CM; Saulnier DM; Spinler JK; Versalovic J
J Bacteriol; 2013 Dec; 195(24):5567-76. PubMed ID: 24123819
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR).
Tenorio-Jiménez C; Martínez-Ramírez MJ; Tercero-Lozano M; Arraiza-Irigoyen C; Del Castillo-Codes I; Olza J; Plaza-Díaz J; Fontana L; Migueles JH; Olivares M; Gil Á; Gomez-Llorente C
BMC Complement Altern Med; 2018 Nov; 18(1):306. PubMed ID: 30453950
[TBL] [Abstract][Full Text] [Related]
40. Randomized control trial on the efficacy of Limosilactobacillus reuteri ATCC PTA 4659 in reducing inflammatory markers in acute uncomplicated diverticulitis.
Ojetti V; Saviano A; Brigida M; Petruzziello C; Caronna M; Gayani G; Franceschi F
Eur J Gastroenterol Hepatol; 2022 May; 34(5):496-502. PubMed ID: 35045564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
